MENU
+Compare
BDTX
Stock ticker: NASDAQ
AS OF
Aug 29 closing price
Price
$2.75
Change
-$0.10 (-3.51%)
Capitalization
156.57M

BDTX Black Diamond Therapeutics Forecast, Technical & Fundamental Analysis

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer... Show more

BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BDTX with price predictions
Aug 29, 2025

BDTX in -4.18% downward trend, declining for three consecutive days on August 29, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BDTX declined for three days, in of 355 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 51 cases where BDTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BDTX as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Aroon Indicator for BDTX entered a downward trend on August 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BDTX's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BDTX just turned positive on August 22, 2025. Looking at past instances where BDTX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

BDTX moved above its 50-day moving average on August 21, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BDTX crossed bullishly above the 50-day moving average on August 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BDTX advanced for three days, in of 241 cases, the price rose further within the following month. The odds of a continued upward trend are .

BDTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.181) is normal, around the industry mean (19.848). P/E Ratio (11.458) is within average values for comparable stocks, (52.253). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.663). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (2.240) is also within normal values, averaging (303.813).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BDTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BDTX is expected to report earnings to rise 17.11% to -22 cents per share on November 10

Black Diamond Therapeutics BDTX Stock Earnings Reports
Q3'25
Est.
$-0.22
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.93
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.09
The last earnings report on August 07 showed earnings per share of -18 cents, beating the estimate of -24 cents. With 565.68K shares outstanding, the current market capitalization sits at 156.57M.
A.I. Advisor
published General Information

General Information

a biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 252-0848
Employees
54
Web
https://www.blackdiamondtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUVU0.040.01
+19.61%
Luvu Brands, Inc.
AGGZF31.35N/A
N/A
AG Growth International Inc.
AMFPF17.46N/A
N/A
Amplifon S.p.A.
RNECY5.85-0.18
-2.99%
Renesas Electronics Corp
CXXIF0.43-0.02
-3.82%
C21 Investments Inc.

BDTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with CGEM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then CGEM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-3.51%
CGEM - BDTX
49%
Loosely correlated
-0.92%
IDYA - BDTX
48%
Loosely correlated
-1.52%
NRIX - BDTX
46%
Loosely correlated
-0.74%
BEAM - BDTX
45%
Loosely correlated
-2.91%
IMNM - BDTX
45%
Loosely correlated
-3.94%
More